Back

Indications, prognosis, and complications of de novo implantable cardioverter defibrillators in patients with type 2 diabetes and without diabetes

31 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Ventricular arrhythmias Device Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Yiran Zhou

Stockholm (Sweden)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Mr F. Mikkelsen (Risskov, DK)
Abstract
Presentation thumbnail
Miss Y. Zhou (Stockholm, SE)
Abstract Video
Presentation thumbnail
Professor L. Fauchier (Tours, FR)
Abstract Video
Presentation thumbnail
Mr H. Kida (Osaka, JP)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Ventricular arrhythmias

The Event

Event poster

ESC Congress 2025

31 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Similar incidence of ICD-shocks in diabetic compared to non-diabetic patients receiving implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D)
thumbnail
Congress Presentation
Indications for de novo pacemaker implantation, prognosis and complications in patients with and without type 2 diabetes mellitus.
thumbnail
Congress Presentation
Sex differences in indications, complications and outcomes of de novo implantable cardioverter defibrillator and cardiac resynchronization therapy: with a focus on diabetes status

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources